SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001013594-21-000722
Filing Date
2021-09-27
Accepted
2021-09-27 16:46:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 thera13g-092721.htm SC 13G 118173
  Complete submission text file 0001013594-21-000722.txt   119719
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 211282211
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155
Business Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155 212-702-8644
Madison Avenue Partners, LP (Filed by) CIK: 0001801265 (see all company filings)

IRS No.: 320567414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G